Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ClickArr: a novel, high-throughput assay for evaluating β-arrestin isoform recruitment. | Front Pharmacol | 2023 | 38027002 | PubTator, text mining | PubMed |
| Gastroblastoma in a 5-year-old child: a case report and literature review. | Front Oncol | 2023 | 38023244 | PubTator, text mining | PubMed |
| A prognostic model for tumor recurrence and progression after meningioma surgery: preselection for further molecular work-up. | Front Oncol | 2023 | 38023177 | PubTator, text mining | PubMed |
| Spontaneous rupture of an arachnoid cyst in an adult: illustrative case. | J Neurosurg Case Lessons | 2023 | 38015025 | PubTator, text mining | PubMed |
| Expression prevalence and dynamics of GPCR somatostatin receptors 2 and 3 as cancer biomarkers beyond NET: a paired immunohistochemistry approach. | Sci Rep | 2023 | 38012197 | PubTator, text mining | PubMed |
| The Connection between MiR-122 and Lymphocytes in Patients Receiving Treatment for Chronic Hepatitis B Virus Infection. | Microorganisms | 2023 | 38004743 | PubTator, text mining | PubMed |
| Bombesins: A New Frontier in Hybrid Compound Development. | Pharmaceutics | 2023 | 38004575 | PubTator, text mining | PubMed |
| Influence of the Molar Activity of 203/212Pb-PSC-PEG2-TOC on Somatostatin Receptor Type 2-Binding and Cell Uptake. | Pharmaceuticals (Basel) | 2023 | 38004470 | PubTator, text mining | PubMed |
| A Critical Analysis of the FDA's Omics-Driven Pharmacodynamic Biomarkers to Establish Biosimilarity. | Pharmaceuticals (Basel) | 2023 | 38004421 | PubTator, text mining | PubMed |
| The FDA's New Guideline "Generally Accepted Scientific Knowledge" (GASK): An Opportunity to Expedite the Approval of Biosimilars. | Pharmaceuticals (Basel) | 2023 | 38004383 | PubTator, text mining | PubMed |
| The Value of ER∝ in the Prognosis of GH- and PRL-Secreting PitNETs: Clinicopathological Correlations. | Int J Mol Sci | 2023 | 38003353 | PubTator, text mining | PubMed |
| Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis. | Cancers (Basel) | 2023 | 38001599 | PubTator, text mining | PubMed |
| Advances in CAR T Cell Therapy for Non-Small Cell Lung Cancer. | Curr Issues Mol Biol | 2023 | 37998743 | PubTator, text mining | PubMed |
| Liver cancer stem cell dissemination and metastasis: uncovering the role of NRCAM in hepatocellular carcinoma. | J Exp Clin Cancer Res | 2023 | 37993901 | PubTator, text mining | PubMed |
| Orthosteric and allosteric modulation of human HCAR2 signaling complex. | Nat Commun | 2023 | 37993467 | PubTator, text mining | PubMed |
| Primary Systemic Vasculitides as a Cause of Group IV Pulmonary Hypertension. | Anatol J Cardiol | 2023 | 37986573 | PubTator, text mining | PubMed |
| Transient spinal cord dysfunction after surgery for intraspinal tumors: A case report. | Medicine (Baltimore) | 2023 | 37960788 | PubTator, text mining | PubMed |
| ASCL1 Is Involved in the Pathogenesis of Schizophrenia by Regulation of Genes Related to Cell Proliferation, Neuronal Signature Formation, and Neuroplasticity. | Int J Mol Sci | 2023 | 37958729 | PubTator, text mining | PubMed |
| Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways. | Int J Mol Sci | 2023 | 37958702 | PubTator, text mining | PubMed |
| Dumping Syndrome: Pragmatic Treatment Options and Experimental Approaches for Improving Clinical Outcomes. | Clin Exp Gastroenterol | 2023 | 37954129 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=20